<tt id="6hsgl"><pre id="6hsgl"><pre id="6hsgl"></pre></pre></tt>
          <nav id="6hsgl"><th id="6hsgl"></th></nav>
          国产免费网站看v片元遮挡,一亚洲一区二区中文字幕,波多野结衣一区二区免费视频,天天色综网,久久综合给合久久狠狠狠,男人的天堂av一二三区,午夜福利看片在线观看,亚洲中文字幕在线无码一区二区 Nation
          Pharma firms start work on H1N1 vaccine
          2009-Jul-7 11:03:08

          China has announced that it would stockpile the H1N1 flu vaccine for 1 percent of the population by Oct 1, even as the 10 designated Chinese vaccine producers are getting busy with development and clinical trials.

          The stockpile of 13 million injections will be used as a preventive measure to counter any sudden outbreak of the flu, Liang Wannian, deputy director of the Ministry of Health's contingency office, said.

          He said the flu vaccine would be chiefly targeted at high-risk groups -- people with prevalent illnesses and pregnant women.

          The first batch of China's H1N1 flu vaccine, developed by these 10 companies, is expected to be ready by the end of the month, and would undergo a two-month clinical trial before it is made available to the public, he said.

          The 10 local vaccine makers include Beijing Sinovac Biotech Co Ltd, Zhuhai Hualan Biological Engineering Inc and Shenzhen Neptunus Interlong Bio-tech Co Ltd.

          Sinovac announced recently that it had completed construction of the H1N1 virus seed bank necessary to produce a virus antigen.

          The company received the seed virus from the US Center for Disease Control on June 8 and started producing the H1N1 vaccine the same day.

          Sinovac said it expected to complete production of the first batch and initiate clinical trials of the vaccine by the end of this month. The flu vaccine has been named PANFLU.

          The company got 100 million yuan on June 29 as loan from the Bank of Beijing, which will be used to purchase pharmaceutical raw material and for expanding its manufacturing facility, according to Sinovac Chairman, President and CEO Yin Weidong. The company's current annual vaccine production capacity is between 20 million and 30 million doses.

          Shenzhen-listed Hualan Biological Engineering Inc said on July 1 that its equity holding subsidiary Hualan Biological Vaccine Co Ltd, a H1N1 vaccine developer, had borrowed 20 million yuan from each of the two shareholders of the parent company to fund its vaccine development effort.

          Hualan can now manufacture nearly 200 million doses annually.

          Li Yingpeng, a pharmaceutical analyst at Galaxy Securities, said 13 million doses of the H1N1 vaccine implied the vaccine makers could net a business of over 300 million yuan, as the average market price of other vaccines in China was around 30 yuan per dose.

          "Though it seems these 10 companies have grabbed the huge business opportunities, they are, at the same time, shouldering high risks," Li said.

          He said since the evolution of the H1N1 flu could not be predicted accurately, the returns on the huge investment required for development of the vaccine and clinical trials could not be guaranteed.

          [Jump to ]
          Nation | Biz | Comment | World | Celebrity | Odds | Sports | Travel | Health
          ChinaDaily Mobile News
          m.chinadaily.com.cn
          To subscribe to China Daily, call 010-64918763 or email to circu@chinadaily.com.cn
          主站蜘蛛池模板: 中文字幕无码中文字幕有码a| 亚洲理论在线A中文字幕| 亚洲国产精品久久久久久无码| 婷婷五月综合激情| 啊轻点灬大JI巴太粗太长了欧美| 这里只有精品国产| 精品人妻av区乱码| 五月色丁香婷婷网蜜臀av| 国产成人精品午夜二三区| 精品久久久中文字幕人妻| 亚洲第一极品精品无码久久| 久久99精品久久水蜜桃| 亚洲一级特黄大片在线播放| 亚洲夂夂婷婷色拍ww47| 久久精品午夜视频| 毛片无码一区二区三区| 亚洲精品成人A在线观看| 日本免费最新高清不卡视频| 一区二区日韩中文字幕| 亚洲乱码中文字幕小综合| 91在线国内在线播放老师 | 欧美另类亚洲一区二区| 天堂va蜜桃一区二区三区| 中文无码人妻有码人妻中文字幕| 日本中文字幕在线播放| 欧美日本国产va高清cabal| 日韩东京热一区二区三区| 亚洲欧美高清在线精品一区二区 | 亚洲av中文乱码一区二| 国内精品免费久久久久电影院97| 久久老熟妇精品免费观看| 久久人人97超碰人人澡爱香蕉| 偷窥少妇久久久久久久久| 亚洲 制服 丝袜 无码| japanese无码中文字幕| 亚洲色无码播放亚洲成av| 成人无码一区二区三区网站| 色噜噜噜亚洲男人的天堂| 99久久久无码国产精品免费| 狠狠色噜噜狠狠亚洲AV| 亚洲AV无码国产在丝袜APP|